Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer VCMap
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
PhenoMiner Database Result        View data table  |  Download data table  |  View expanded data table        

Generate Chart For    
    (Chart displayed below)
Rat Strains
{{sample.term}}
Measurement Methods
{{method.term}}
Age
{{ageRange}}
Experimental Conditions
     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View expanded data table
# of AnimalsPhenotypeStrainSexValueUnitsConditionsRecord IDCondition 1aCondition 1bCondition 2
10post-insult time to onset of diabetes mellitusWF.BBDR-(D4Got39-D4Rat44)/Wornot specified17danti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) 66156anti-RT6.1 antibody (1 ml) Poly I:C (2.5 ug/g)
12post-insult time to onset of diabetes mellitusWF.BBDR-(D4Rat96-D4Rat44)/Wornot specified24danti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) 66158anti-RT6.1 antibody (1 ml) Poly I:C (2.5 ug/g)
5post-insult time to onset of diabetes mellitusWF.BBDR-(D4Arb29-D4Rat265)/Wornot specified30danti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) 66162anti-RT6.1 antibody (1 ml) Poly I:C (2.5 ug/g)
10post-insult time to onset of diabetes mellitusWF.BBDR-(D4Arb29-D4Rat96)/Wornot specified30danti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) 66164anti-RT6.1 antibody (1 ml) Poly I:C (2.5 ug/g)
18post-insult time to onset of diabetes mellitusWF.BBDR-(D4Arb29-D4Rat44)/Wornot specified20danti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) 66165anti-RT6.1 antibody (1 ml) Poly I:C (2.5 ug/g)
12post-insult time to onset of diabetes mellitusBBDR/Rhwnot specified11danti-RT6.1 antibody (2 ml) (for 28 days) and Poly I:C (5 ug/g) (for 28 days)66148anti-RT6.1 antibody (2 ml) (for 28 days)Poly I:C (5 ug/g) (for 28 days)
10percentage of study population developing type 1 diabetes mellitus during a period of timeWF.BBDR-(D4Got39-D4Rat44)/Wornot specified30%anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) 66154anti-RT6.1 antibody (1 ml) Poly I:C (2.5 ug/g)
12percentage of study population developing type 1 diabetes mellitus during a period of timeWF.BBDR-(D4Got51-D4Rat44)/Wornot specified0%anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) 66155anti-RT6.1 antibody (1 ml) Poly I:C (2.5 ug/g)
12percentage of study population developing type 1 diabetes mellitus during a period of timeWF.BBDR-(D4Rat96-D4Rat44)/Wornot specified58%anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) 66157anti-RT6.1 antibody (1 ml) Poly I:C (2.5 ug/g)
18percentage of study population developing type 1 diabetes mellitus during a period of timeWF.BBDR-(D4Arb29-D4Rat44)/Wornot specified39%anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) 66159anti-RT6.1 antibody (1 ml) Poly I:C (2.5 ug/g)
4percentage of study population developing type 1 diabetes mellitus during a period of timeWF.BBDR-(D4Rat16-D4Got39)/Wornot specified0%anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) 66160anti-RT6.1 antibody (1 ml) Poly I:C (2.5 ug/g)
5percentage of study population developing type 1 diabetes mellitus during a period of timeWF.BBDR-(D4Arb29-D4Rat265)/Wornot specified40%anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) 66161anti-RT6.1 antibody (1 ml) Poly I:C (2.5 ug/g)
10percentage of study population developing type 1 diabetes mellitus during a period of timeWF.BBDR-(D4Arb29-D4Rat96)/Wornot specified20%anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) 66163anti-RT6.1 antibody (1 ml) Poly I:C (2.5 ug/g)
12percentage of study population developing type 1 diabetes mellitus during a period of timeBBDR/Rhwnot specified100%anti-RT6.1 antibody (2 ml) (for 28 days) and Poly I:C (5 ug/g) (for 28 days)66147anti-RT6.1 antibody (2 ml) (for 28 days)Poly I:C (5 ug/g) (for 28 days)
N/Apercentage of study population developing type 1 diabetes mellitus during a period of timeWF.BBDR-(D4Rat96-D4Rat44)/Wornot specified58%anti-RT6.1 antibody (for 30 days) and Poly I:C (2.5 ug/g) (for 30 days)66166anti-RT6.1 antibody (for 30 days)Poly I:C (2.5 ug/g) (for 30 days)
N/Apercentage of study population developing type 1 diabetes mellitus during a period of timeWF.BBDR-(D4Got48-D4Got43)/Wornot specified13%anti-RT6.1 antibody (for 30 days) and Poly I:C (2.5 ug/g) (for 30 days)66167anti-RT6.1 antibody (for 30 days)Poly I:C (2.5 ug/g) (for 30 days)
N/Apercentage of study population developing type 1 diabetes mellitus during a period of timeWF.BBDR-(D4Rat93-D4Rat228)/Wornot specified52%anti-RT6.1 antibody (for 30 days) and Poly I:C (2.5 ug/g) (for 30 days)66168anti-RT6.1 antibody (for 30 days)Poly I:C (2.5 ug/g) (for 30 days)
N/Apercentage of study population developing type 1 diabetes mellitus during a period of timeWF.BBDR-(Clcn1-D4Rat228)/Wornot specified0%anti-RT6.1 antibody (for 30 days) and Poly I:C (2.5 ug/g) (for 30 days)66169anti-RT6.1 antibody (for 30 days)Poly I:C (2.5 ug/g) (for 30 days)
27percentage of study population developing diabetes mellitus during a period of timeBBDR/Worboth100%Poly I:C (1 ug/g) then Kilham rat virus (10000000 PFU) 68747Poly I:C (1 ug/g) Kilham rat virus (10000000 PFU)
12percentage of study population developing diabetes mellitus during a period of timeBBDR/Worboth100%Poly I:C (1 ug/g) (for 40 days) and anti-RT6.1 antibody (25 ug) (for 40 days)68796Poly I:C (1 ug/g) (for 40 days)anti-RT6.1 antibody (25 ug) (for 40 days)
6percentage of study population developing diabetes mellitus during a period of timeBBDR/Worboth0%Poly I:C (1 ug/g) 68797Poly I:C (1 ug/g)
8percentage of study population developing diabetes mellitus during a period of timeWF.BBDR-ART2a/Worboth0%Poly I:C (1 ug/g) then Kilham rat virus (10000000 PFU) 68799Poly I:C (1 ug/g) Kilham rat virus (10000000 PFU)
53percentage of study population developing diabetes mellitus during a period of timeWF.BBDR-ART2a/Worboth0.1%Poly I:C (1 ug/g) (for 40 days) and anti-RT6.1 antibody (25 ug) (for 40 days)68800Poly I:C (1 ug/g) (for 40 days)anti-RT6.1 antibody (25 ug) (for 40 days)
18percentage of study population developing diabetes mellitus during a period of timeWF.BBDR-(D4Got51-D4Rat44)/Worboth0%Poly I:C (1 ug/g) then Kilham rat virus (10000000 PFU) 69366Poly I:C (1 ug/g) Kilham rat virus (10000000 PFU)
12percentage of study population developing diabetes mellitus during a period of timeWF.BBDR-(D4Got51-D4Rat44)/Worboth0.6%Poly I:C (1 ug/g) (for 40 days) and anti-RT6.1 antibody (25 ug) (for 40 days)69367Poly I:C (1 ug/g) (for 40 days)anti-RT6.1 antibody (25 ug) (for 40 days)

Contact Us |  About Us |  Jobs at RGD